Hospira gets FDA nod for Taxotere knockoff; Purdue lobbies Florida on pain pill mills;

@FiercePharma: Lilly CEO: No need for megadeals, we have Japan. Story |  Follow @FiercePharma 

> Hospira has won approval for the first U.S. generic version of Sanofi-Aventis' big-selling Taxotere cancer drug. The news sent Hospira shares up 2 percent. Report

> Purdue Pharma, the manufacturer of the pain drug OxyContin, offered Florida $1 million to set up a controversial computer system that would help crack down on pill mills. News | Story 

> Merck is launching a major corporate social responsibility initiative, reports PRWeek, focusing on the company's role in global health. Article

> A settlement in a class-action lawsuit over Solvay Pharma's hormone replacement therapy has produced a financial windfall for four Nashville organizations. Story

> A federal panel meets Thursday to evaluate growing concerns about whether anesthesia in young children, used in millions of surgical procedures, can lead to cognitive problems or learning disabilities. News

> Is a medical journal ad for platelet-inhibition testing backed up by evidence that treatment guided by such testing can reduce the risk of clot formation? Report

> Researchers have identified the first disease-specific biomarker for sporadic Creutzfeldt-Jakob disease (sCJD), or so-called mad cow disease, a universally fatal, degenerative brain disease for which there is no cure. Article

> The Obama administration is asking a federal appeals court in Atlanta to act swiftly on a lawsuit challenging the constitutionality of the government's healthcare overhaul. Story

> An FDA advisory panel said genetic tests directly marketed to consumers should be allowed only under a doctor's supervision. Item

Biotech News

@FierceBiotech: Analysts jolted by Pharmasset's stellar data on combo hep C treatment. News | Follow @FierceBiotech

@JohnCFierce: In the meantime, I'll be taking off for Rome tomorrow, on way to BIO Europe for biotech panel discussion. Follow @JohnCFierce

> ARYx Therapeutics will close shop after FDA delay scuttles financing. News 

> Europeans inject $241M into new round of development projects. Report 

> Benlysta: Timeline of a lupus drug. Story

> Bill Gates backs fledgling computational drug discovery upstart. Item 

> Evotec teams up with Harvard, HHMI on diabetes drugs. Report 

Vaccines News

> Cancer vax developer Kite lands $15M. Story

> Gates steps in to vaccine VC with $10M investment. Item 

> Virus present up to one month after Zostavax immunization. Report

> BiovaxID gets EMA orphan status. News 

> Japan: No link between child deaths, vaccines. Article

Manufacturing News

> Bill elevates drug theft to organized crime status. News 

> FDA works to avert cancer drug shortage. Report 

> J&J shortage links eBay to drug supply chain. Item 

> Study finds fuzzy price/drug-quality link. Report 

> Demand, speculators threaten Chinese medicine plants. Article 

And Finally... From birth through old age, Americans have poorer health than their British counterparts, a new study finds. Report

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.